Editas Medicine, Inc. financial data

Symbol
EDIT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
11 Hurley St., Cambridge, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 595 % -25.6%
Debt-to-equity 41.5 % +21.5%
Return On Equity -47.3 % +15.8%
Return On Assets -33.5 % +20.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 82.2 M shares +19.2%
Common Stock, Shares, Outstanding 82.2 M shares +19.2%
Entity Public Float 671 M USD +5.89%
Common Stock, Value, Issued 8 K USD +14.3%
Weighted Average Number of Shares Outstanding, Basic 81.9 M shares +18.9%
Weighted Average Number of Shares Outstanding, Diluted 81.9 M shares +18.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 69.4 M USD +205%
Research and Development Expense 189 M USD +7.92%
General and Administrative Expense 66 M USD -11%
Operating Income (Loss) -185 M USD +18.1%
Nonoperating Income (Expense) 19.1 M USD +165%
Net Income (Loss) Attributable to Parent -166 M USD +24.1%
Earnings Per Share, Basic -2.07 USD/shares +34.9%
Earnings Per Share, Diluted -2.07 USD/shares +34.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 69.2 M USD -46.3%
Marketable Securities, Current 227 M USD +19.8%
Assets, Current 306 M USD -5.83%
Property, Plant and Equipment, Net 13.3 M USD +0.35%
Operating Lease, Right-of-Use Asset 31.4 M USD -13.5%
Other Assets, Noncurrent 9.49 M USD +40.5%
Assets 440 M USD -5.12%
Accounts Payable, Current 7.97 M USD -11.9%
Employee-related Liabilities, Current 8.65 M USD +45.2%
Accrued Liabilities, Current 31.5 M USD -0.25%
Contract with Customer, Liability, Current 14.7 M USD +78.6%
Liabilities, Current 66.5 M USD +16.3%
Contract with Customer, Liability, Noncurrent 54.2 M USD -10.7%
Operating Lease, Liability, Noncurrent 21.8 M USD -24.4%
Other Liabilities, Noncurrent 3.47 M USD
Liabilities 146 M USD -0.47%
Accumulated Other Comprehensive Income (Loss), Net of Tax -326 K USD +85.7%
Retained Earnings (Accumulated Deficit) -1.29 B USD -14.7%
Stockholders' Equity Attributable to Parent 294 M USD -7.27%
Liabilities and Equity 440 M USD -5.12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -49.9 M USD -39.4%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities -4.75 M USD -120%
Common Stock, Shares Authorized 195 M shares 0%
Common Stock, Shares, Issued 82.2 M shares +19.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -54.4 M USD -335%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 73.1 M USD -45%
Deferred Tax Assets, Valuation Allowance 329 M USD +11%
Deferred Tax Assets, Gross 338 M USD +9.45%
Operating Lease, Liability 36.5 M USD -16.9%
Depreciation 1.41 M USD -8.74%
Payments to Acquire Property, Plant, and Equipment 1.87 M USD +1.69%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -164 M USD +24.9%
Lessee, Operating Lease, Liability, to be Paid 43.4 M USD -19.6%
Property, Plant and Equipment, Gross 40.8 M USD +16.1%
Operating Lease, Liability, Current 12.4 M USD +48.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.39 M USD -32.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.8 M USD +2.02%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.91 M USD -31.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.13 M USD +0.08%
Deferred Tax Assets, Operating Loss Carryforwards 153 M USD +5.88%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 13.7 M USD +15.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.08 M USD +2.11%
Operating Lease, Payments 3.85 M USD -1.28%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 9.19 M USD -26.8%
Share-based Payment Arrangement, Expense 22.9 M USD +2.26%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%